Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP904874.RAizF6p3HZzsRmAI-oQ7K-vYiZJOc7WVVhmWNtl7G7TKs130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904874.RAizF6p3HZzsRmAI-oQ7K-vYiZJOc7WVVhmWNtl7G7TKs130_provenance.
• NP640456.RAoX7tONE_kxKocR51uYI0LHVETcLwii6j0cfoFcefiWM130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640456.RAoX7tONE_kxKocR51uYI0LHVETcLwii6j0cfoFcefiWM130_provenance.
• NP493735.RAe45VbKumA8BtxXngtgEuH7wCpUF2I0sN2qMW_hdJDOw130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493735.RAe45VbKumA8BtxXngtgEuH7wCpUF2I0sN2qMW_hdJDOw130_provenance.
• NP467236.RAVDJLEfsdrab21V7vcSMwyK_ld9XIyDO3072M6JgELM0130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467236.RAVDJLEfsdrab21V7vcSMwyK_ld9XIyDO3072M6JgELM0130_provenance.
• assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP390174.RAWKrBf3PwhIJgwDzsgjkaViyx6x9mNC38pAVG1nHYbgo130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390174.RAWKrBf3PwhIJgwDzsgjkaViyx6x9mNC38pAVG1nHYbgo130_provenance.
• NP758072.RAyYns0QmV5NsgFDNPZW5OElZeJBCBZ-rBB31w1Ia3QF8130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758072.RAyYns0QmV5NsgFDNPZW5OElZeJBCBZ-rBB31w1Ia3QF8130_provenance.
• NP868460.RA7yqrOoa6fVecRlxYCxmlp1qpZtX18btwJn9EI_x7I-0130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868460.RA7yqrOoa6fVecRlxYCxmlp1qpZtX18btwJn9EI_x7I-0130_provenance.
• NP505016.RAIBVY5Azm3HpeXk_fY-MfZ7SRKoV5grHlsvnDqaIyJEk130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505016.RAIBVY5Azm3HpeXk_fY-MfZ7SRKoV5grHlsvnDqaIyJEk130_provenance.
• assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP537782.RARji13Y_dElYAOTPy43EAed004HFI8C-u-rNzqdMR5hQ130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537782.RARji13Y_dElYAOTPy43EAed004HFI8C-u-rNzqdMR5hQ130_provenance.
• assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP537778.RAs3QmRgLUg90mycjbylbwewURHIHlnuE5jYZ9UVsy1ig130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537778.RAs3QmRgLUg90mycjbylbwewURHIHlnuE5jYZ9UVsy1ig130_provenance.
• NP537784.RAgfRZgyd0ZFX1JkKE5KegLZkJbDRQeKTTjjA4kJ_LuaU130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537784.RAgfRZgyd0ZFX1JkKE5KegLZkJbDRQeKTTjjA4kJ_LuaU130_provenance.
• NP609043.RA8bxbLxtbJk8Kdp68VcQ0Mi0aLkTWCodSmNT8UhySu2Y130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609043.RA8bxbLxtbJk8Kdp68VcQ0Mi0aLkTWCodSmNT8UhySu2Y130_provenance.
• NP987005.RALZf40CBhTt2gy4sN5S9Dsbl5stTBGdZmauwTaa-Neto130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP987005.RALZf40CBhTt2gy4sN5S9Dsbl5stTBGdZmauwTaa-Neto130_provenance.
• NP812865.RALFMTO_0rZz4--CBBSb6dbuHzmv3YAiLiAXQC21ba2y0130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812865.RALFMTO_0rZz4--CBBSb6dbuHzmv3YAiLiAXQC21ba2y0130_provenance.
• NP943805.RANlWiTifqu4iHfuGK1xI4lIWCl8CPQz_ZRWIZnTqxnMk130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943805.RANlWiTifqu4iHfuGK1xI4lIWCl8CPQz_ZRWIZnTqxnMk130_provenance.
• NP974513.RAHO2L7dCUzZgAjv6wYT83NqKqZbS8APhurse7v40XWBY130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974513.RAHO2L7dCUzZgAjv6wYT83NqKqZbS8APhurse7v40XWBY130_provenance.
• NP537786.RAFDaiEB8Fw_yFUx2QpC1Zdzmx0VhfuvkviNEOzytDGk4130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537786.RAFDaiEB8Fw_yFUx2QpC1Zdzmx0VhfuvkviNEOzytDGk4130_provenance.
• NP808983.RA0hRo5hwEw_zqs20VRwG3byoqxc38obSL25YyelbZ9I0130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808983.RA0hRo5hwEw_zqs20VRwG3byoqxc38obSL25YyelbZ9I0130_provenance.
• NP537774.RA9_XRTUDZV7mJQn-sz5NHRzZwm_zMuQwRzpJr7HrbCjI130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537774.RA9_XRTUDZV7mJQn-sz5NHRzZwm_zMuQwRzpJr7HrbCjI130_provenance.
• NP537776.RA2onekC1_l1IF53YUwvj-YU2Cnr2s1UO-MIR382VHMkw130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537776.RA2onekC1_l1IF53YUwvj-YU2Cnr2s1UO-MIR382VHMkw130_provenance.
• NP537780.RAz30GrhBr2w42o1cfnXzb8B9adpaiYnpyd9HVFkC1aNI130_assertion description "[Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537780.RAz30GrhBr2w42o1cfnXzb8B9adpaiYnpyd9HVFkC1aNI130_provenance.